Tag Archives: NDEA
-
-
FDA Releases List of 40 Hypertension Drugs That Do Not Contain Potentially Cancer-Causing Impurities
-
Cancer-Causing Impurities Made Recalled Valsartan an Unapproved Drugs: Lawsuit
-
Valsartan Recall Lawyers to Meet with Judge Presiding Over Federal Litigation
-
Valsartan Recalls Are “Stress Test” For U.S. Drug Supply Chain: NEJM Editorial
-
Generic Valsartan Shortages Following Contamination Recalls Lead FDA To Prioritize Approval of New Drugs
-
Valsartan Contamination Lawsuits Stayed Pending Entry of Case Management Order
-
Colorectal Cancer from Valsartan Contamination Resulted in Wrongful Death, Lawsuit Alleges
-
Valsartan and Losartan Recalls Expanded As New Potentially Cancer-Causing Impurities Found
-
Stomach Cancer Lawsuit Filed Against Manufacturers of Recalled Generic Valsartan